Nordic-Irish Process Chemistry Forum 2023

6 June 2023 11:30 - 8 June 2023 12:30, Belfast, United Kingdom

Almac are delighted to host this free event, which not only includes experts from industry and academia, but provides PhD students with the opportunity to showcase their research studies.  Don't miss the opportunity to be involved in this prestigous event! 

The main driver of the forum has been to bring scientists together who are involved in the design and scale up of chemical processes, and this year's forum is no exception. The event facilitates networking, addresses pertinent chemical challenges, fosters idea sharing and hosts new chemical trends.

The Nordic Process Chemistry Forum itself has a long history of attracting some of the most respected and innovative speakers in the world of chemistry, and we have already secured a fantastic line-up of industry speakers.  Download our agenda to discover more.

Participation opportunities:
  • Five Minutes of Fame: novel technology or exciting PhD research you want to shout about? We are seeking to showcase talent with an opportunity for you to present synthetic technologies within a 5-10 minute slot. These technology showcases will be judged by experts in the field and a prize will be awarded to the winner. 
  • Poster Presentations: we also have showcase opportunities via poster presentations. Download and complete the abstract submission form from our website to be considered.
  • Exhibit: this is a cost-effective way to showcase the latest solutions you have to offer and raise your profile among the pharma community.
W5 Interactive Discovery Centre

Lecture Theatre, W5 Interactive Discovery Centre, 2 Queens Quay, Belfast, BT3 9QQ, United Kingdom

Organised by
The Almac Group is an established contract development and manufacturing organisation providing an extensive range of integrated services across the drug development lifecycle to the pharmaceutical and biotech sectors globally.

Our innovative services range from R&D, biomarker discovery, development and commercialisation, API manufacture, formulation development, clinical trial supply, IRT (IVRS/IWRS) through to commercial-scale manufacture.

The international company is a privately owned organisation that has grown organically over the past five decades now employing over 6600+ highly skilled personnel across 18 facilities including Europe, the US and Asia. 

We have a global reputation for excellence built over 50 years of client service, initially as Galen and then as the wider Almac Group including  Galen, delivering expertise right across the drug development lifecycle and offering a tailored solution to each of our clients.

About Almac Sciences
Think Almac for API development & manufacturing solutions

With 900 highly skilled employees, spanning across 4 locations globally, Almac Sciences provides services for all stages of drug development for small molecules and peptides.  Our expertise includes: API supply (pre-clinical to commercial manufacture); drug product development; stable and 14C radiolabelling; solid state services and, biocatalysis, all of which are fully supported by a dedicated Analytical team.
Contact information
Showing all upcoming events
Start Date
End Date
Subject area
Event type


E-mail Enquiry